Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0285307 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Tina Taule und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Therapy, Orthopedic Clinic, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Cognition Disorders, Amyotrophic Lateral Sclerosis, Alzheimer Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest Regionalt Helseføretak.
Abstract (Originalsprache)
Background
Research collaboration highlight a need for validated tests in other languages than English. Translation and culture adjustments may threaten essential features of the original instrument.
Objective
To assess the internal consistency, inter-rater and test-retest reliability, and construct validity of the Norwegian version of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis (ALS) Screen (ECAS-N).
Methods
Performance of 71 subjects with ALS, 85 healthy controls (HC) and 6 controls with Alzheimer’s disease (AD) were assessed with the ECAS-N. Test-retest interval was four months. Internal consistency was evaluated using Cronbach’s alpha; reliability was assessed using intraclass correlation coefficient (ICC), Cohen’s kappa, and Bland Altman plot. Five hypothesis, including the Montreal Cognitive Assessment (MoCA) screen, was evaluated for construct validity.
Results
ECAS-N total score produced a Cronbach’s alpha of 0.65, had excellent inter-rater reliability (ICC = 0.99) and acceptable test-retest reliability (ICC = 0.73). Construct validity analysis suggested valid use of the ECAS-N to distinguish people with ALS-specific cognitive impairment from HC (p = 0.001) and those with AD (p = 0.002). The MoCA and ECAS-N were moderately correlated (r = 0.53).
Conclusion
The ECAS-N has potential to be used by different testers in clinical practice and research to screen patients with ALS who speak Norwegian and for documenting cognitive impairment over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Occupational Therapy, Orthopedic Clinic, Haukeland University Hospital, Bergen, Norway.
- Department of Rehabilitation Services, Haraldsplass Deaconess Hospital, Bergen, Norway.
- Department of Physio and Occupational Therapy, Namsos hospital, Nord-Trøndelag Hospital Trust, Namsos, Norway.
- Department of Clinical Services, St. Olav's University Hospital, Trondheim, Norway.
- Department of Social Work, Occupational Therapy and Physiotherapy, Hospital of Southern Norway, Kristiansand, Norway.
- Department of Neurology, Neurologic Clinic, Haukeland University Hospital, Bergen, Norway.
ORCID-Profile: Tina Taule, Marit Sofie Oseland, Tiina Rekand
Förderung
- Helse Vest Regionalt Helseføretak
Zitieren
APA
Taule, T., Eide, I. S., Fjær, L., Myrberget, M. A., Oseland, M. S., Renså, M. A., Revheim, T., Tysnes, O. B., Aßmus, J., & Rekand, T. (2023). Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability. PLOS ONE. https://doi.org/10.1371/journal.pone.0285307
Vancouver
Taule T, Eide IS, Fjær L, Myrberget MA, Oseland MS, Renså MA, et al. Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability. PLOS ONE. 2023. doi:10.1371/journal.pone.0285307
BibTeX
@article{Taule2023,
author = {Taule, Tina and Eide, Irmelin Smith and Fjær, Line and Myrberget, Mari-Anne and Oseland, Marit Sofie and Renså, Marit Arnevik and Revheim, Tone and Tysnes, Ole-Bjørn and Aßmus, Jörg and Rekand, Tiina},
title = {Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285307}
}
EUVIMED